FINWIRES · TerminalLIVE
FINWIRES

Zscaler's Fiscal 2027 Outlook Shows Cautious Tone Despite AI Momentum, RBC Says

By

Zscaler's (ZS) fiscal 2027 outlook topped its preliminary range, yet still carried a cautious tone amid a sales-leadership transition and slower-than-expected uptake of a new security product, even as AI momentum builds across its platform, RBC Capital Markets said Thursday in a report.

The company expects fiscal 2027 annual recurring revenue of $4.40 billion to $4.43 billion, revenue of $3.91 billion to $3.94 billion, and adjusted EPS of $4.86 to $4.90, the report said.

Zscaler's growing use of AI and the rollout of its new Agentic SecOps tools, designed to automate parts of security operations, may help results H2 2027, RBC said. Additional hiring, stronger partner activity and continued traction in its Z-Flex and data-security offerings might also support upside to estimates, the report said.

RBC raised its price target on Zscaler stock to $210 from $200 and maintained its outperform rating.

Price: $169.21, Change: $-8.59, Percent Change: -4.83%

Related Articles

Wire

Vaxcyte Names New Medical and Legal Chiefs Ahead of Key Phase 3 Data

Vaxcyte (PCVX) appointed Luis Jodar as chief medical officer and David McAvoy as chief legal officer, the company said on Thursday.Jodar spent 17 years at Pfizer (PFE), most recently as senior vice president and chief medical officer for Vaccines and Infectious Diseases, the company said.McAvoy joins the company from Teva Pharmaceutical (TEVA), according to a statement.The vaccine developer also said it now expects to report topline data from its phase 3 OPUS-1 trial of VAX-31 in adults by the end of October, narrowing its previous guidance of a Q4 data release.

$PCVX
Wire

eGain Fiscal Q4 Adjusted Earnings, Revenue Fall; Shares Slump After Hours

EGain (EGAN) reported fiscal Q4 adjusted earnings late Thursday of $0.08 per diluted share, down from $0.09 a year earlier.Three analysts polled by FactSet projected $0.03.Revenue in the three months ended June 30 fell to $22.2 million from $23.2 million a year earlier.Three analysts projected $21.7 million.The company expects fiscal Q1 adjusted EPS of $0.05 to $0.08 on revenue of $20.9 million to $21.4 million. Three analysts project EPS of $0.08 on revenue of $22.3 million.For fiscal 2027, eGain expects adjusted EPS of $0.04 to $0.07 on revenue of $84.5 million to $86 million. Three analysts project EPS of $0.43 on revenue of $94.1 million.EGain shares slumped 29% in after-hours trading.

$EGAN
Wire

American Outdoor Brands Fiscal Q1 Swings to Adjusted Earnings, Revenue Rises

American Outdoor Brands (AOUT) reported fiscal Q1 non-GAAP earnings late Thursday of $0.03 per diluted share, swinging from a loss $0.26 year earlier.Two analysts polled by FactSet expected a loss of $0.24.Net sales for the quarter ended July 31 were $37.3 million, up from $29.7 million a year earlier.Two analysts expected $35.6 million.For fiscal 2027, the company maintained its net sales forecast of $200 million to $210 million. Two analysts expect $205.1 million.Shares of the company rose over 16% in after-hours trading.

$AOUT